![Peter Geoffrey Welch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Geoffrey Welch
Direttore/Membro del Consiglio presso LKM Innovations Ltd.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Dave Scott | M | 67 |
LKM Innovations Ltd.
![]() LKM Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Part of LumiraDx Ltd. (Cayman Islands), LKM Innovations Ltd. is a British company founded in 2009 that specializes in fast lab solutions. The company is based in Stirling, UK. LKM Innovations operates as a dedicated LumiraDx business unit that supports high-complexity laboratory testing by utilizing its innovative qstar nucleic acid amplification technology in an accessible high-throughput format to leverage current molecular laboratory operations. The LumiraDx D-dimer test is an easy-to-use fluorescence immunoassay designed to rapidly quantify D-dimer levels in human whole blood and plasma at the point of care, providing lab-comparable results in minutes. | - |
Ron Zwanziger | M | 70 |
Treisar Investments Ltd.
![]() Treisar Investments Ltd. Financial ConglomeratesFinance Treisar Investments Ltd. provides investment services. The private company is based in London, UK and was founded in 2015. | - |
Jerome Francis Francis McAleer | M | 69 |
LKM Innovations Ltd.
![]() LKM Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Part of LumiraDx Ltd. (Cayman Islands), LKM Innovations Ltd. is a British company founded in 2009 that specializes in fast lab solutions. The company is based in Stirling, UK. LKM Innovations operates as a dedicated LumiraDx business unit that supports high-complexity laboratory testing by utilizing its innovative qstar nucleic acid amplification technology in an accessible high-throughput format to leverage current molecular laboratory operations. The LumiraDx D-dimer test is an easy-to-use fluorescence immunoassay designed to rapidly quantify D-dimer levels in human whole blood and plasma at the point of care, providing lab-comparable results in minutes. | - |
Steven Keatch | M | 46 |
LKM Innovations Ltd.
![]() LKM Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Part of LumiraDx Ltd. (Cayman Islands), LKM Innovations Ltd. is a British company founded in 2009 that specializes in fast lab solutions. The company is based in Stirling, UK. LKM Innovations operates as a dedicated LumiraDx business unit that supports high-complexity laboratory testing by utilizing its innovative qstar nucleic acid amplification technology in an accessible high-throughput format to leverage current molecular laboratory operations. The LumiraDx D-dimer test is an easy-to-use fluorescence immunoassay designed to rapidly quantify D-dimer levels in human whole blood and plasma at the point of care, providing lab-comparable results in minutes. | - |
Phillip Lowe | M | 48 |
LKM Innovations Ltd.
![]() LKM Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Part of LumiraDx Ltd. (Cayman Islands), LKM Innovations Ltd. is a British company founded in 2009 that specializes in fast lab solutions. The company is based in Stirling, UK. LKM Innovations operates as a dedicated LumiraDx business unit that supports high-complexity laboratory testing by utilizing its innovative qstar nucleic acid amplification technology in an accessible high-throughput format to leverage current molecular laboratory operations. The LumiraDx D-dimer test is an easy-to-use fluorescence immunoassay designed to rapidly quantify D-dimer levels in human whole blood and plasma at the point of care, providing lab-comparable results in minutes. | - |
Brian McGuigan | M | 44 |
LKM Innovations Ltd.
![]() LKM Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Part of LumiraDx Ltd. (Cayman Islands), LKM Innovations Ltd. is a British company founded in 2009 that specializes in fast lab solutions. The company is based in Stirling, UK. LKM Innovations operates as a dedicated LumiraDx business unit that supports high-complexity laboratory testing by utilizing its innovative qstar nucleic acid amplification technology in an accessible high-throughput format to leverage current molecular laboratory operations. The LumiraDx D-dimer test is an easy-to-use fluorescence immunoassay designed to rapidly quantify D-dimer levels in human whole blood and plasma at the point of care, providing lab-comparable results in minutes. | - |
Veronique Ameye | F | 47 |
LumiraDx Investment Ltd.
![]() LumiraDx Investment Ltd. Medical SpecialtiesHealth Technology Part of LumiraDx Ltd. (Cayman Islands), LumiraDx Investment Ltd. is a British company that manufactures medical and dental instruments. The company is based in London, UK and was founded in 2016. | 8 anni |
Saar Shafir | M | 49 |
Treisar Investments Ltd.
![]() Treisar Investments Ltd. Financial ConglomeratesFinance Treisar Investments Ltd. provides investment services. The private company is based in London, UK and was founded in 2015. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Regno Unito | 8 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Peter Geoffrey Welch
- Contatti personali